The “glue grant” – so-called because it brings together multidisciplinary groups of investigators – was awarded to provide resources to tackle the “complex problems that are of central importance to biomedical science but are beyond the means of any one research group,” according to the NIGMS.
Gerlt’s team will develop a strategy for discovering the functions of unknown, or uncharacterized, enzymes discovered in genome-sequencing projects.
“Genome projects have taught us that many of nature’s enzymes have unknown functions that need to be discovered,” said Gerlt, an expert on the enolase superfamily of enzymes.
Enzymes are proteins that catalyze the chemical reactions required for life, and enable organisms to live in complex environments and adapt to a variety of conditions.“We have sequences for more than 10 million proteins and we might know the specific functions of half of those,” Gerlt said. “But what do the other half do? If we knew their functions, imagine how we might use them to identify new drug targets or provide catalysts used in industry.”
Gerlt says this project is a potentially powerful way to exploit the sequence data that have not yet been deciphered; it also could provide a way to learn more about metabolic pathways crucial to all organisms.
For the glue grant, officially known as the Enzyme Function Initiative, Gerlt and Babbitt have assembled a team of researchers from several disciplines to determine the structure of an unknown enzyme and then, computationally, determine a “hit list” of possible substrates, numbering in the tens, rather than the thousands.
The team of researchers comprises scientists from the Albert Einstein College of Medicine, Boston University, Texas A&M University, the University of New Mexico, the University of Utah, the Vanderbilt University School of Medicine and the University of Virginia.
The team also includes a microbiology group led by John Cronan, a professor of microbiology at Illinois, and Jonathan Sweedler, a professor of chemistry at Illinois.
“This program gathers together an outstanding group of researchers who will use their expertise in enzymology, structural biology, computational modeling and bioinformatics to develop an approach to associate enzymatic functions with genes in thousands of organisms,” said Warren Jones, the chief of the biochemistry and biorelated chemistry branch in the division of pharmacology, physiology and biological chemistry at the NIGMS.
Diana Yates | University of Illinois
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences